OPKO Health (NASDAQ:OPK) reported quarterly losses of $(0.10) per share which missed the analyst consensus estimate of $(0.07) by 42.86 percent. This is a 16.67 percent increase over losses of $(0.12) per share from the same period last year. The company reported quarterly sales of $149.90 million which missed the analyst consensus estimate of $164.26 million by 8.74 percent. This is a 13.70 percent decrease over sales of $173.70 million the same period last year.